News

Piperacillin Sodium/Tazobactam Sodium exported to US

ABOUT US

News

Piperacillin Sodium/Tazobactam Sodium exported to US

Release time：

2018-12-21

Qilu Pharmaceutical announces that Piperacillin Sodium/ Tazobactam Sodium for injection manufactured by its subsidiary Qilu Tianhe Pharmaceutical was exported to the US on December 21, 2018. Up to now, Qilu has launched eleven products in US and among them, nine products are injectables.

Qilu is the only pharmaceutical company in China that exported the above product to EU, Japan and US with a total volume of over 20 million vials so far.

Qilu Pharma Announces Launch of a Generic Version of Cialis ® in the United States

Qilu Launches Generic Aloxi® Injection in the US

Related News

Qilu Pharmaceutical ranks No.3 in the list of "Top 100 Enterprises in Chinese Pharmaceutical industry”

2024-09-30

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”